Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Yunlong Wang · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
atrial-fibrillationcatheter-ablation
atrial fibrillation, obesity & overweight, catheter ablation, tirzepatide, gip/glp-1 receptor agonist, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909579
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.